CytoBioscience, Inc is a manufacturing company founded in 1989 and headquartered in the United States. The company specializes in providing complete automated patch clamp solutions for research and screening purposes, offering instruments designed to simplify the patch clamp process and resulting in significant time and cost reductions for customers. In addition to the automated solutions, CytoBioscience also offers consultation services to optimize systems and assays for customers, as well as outsourcing options for patch clamp ion channel research and screening from its laboratory facilities in San Antonio, TX.
The latest investment in CytoBioscience, Inc was a $1.53M Venture Round investment, which took place on 19 March 2018. The specifics of the investors involved in this round were not disclosed.